CDC identifies ‘strong culprit’ in vaping-related lung illnesses

U.S. health officials announced a breakthrough Friday into the cause of a mysterious outbreak of vaping illnesses, reporting they have a “very strong culprit.” The same chemical compound was found in fluid taken from the lungs of 29 patients across the country, the Centers for Disease Control and Prevention said. The compound — vitamin E acetate — was previously found […]

Read more

U.S. drug-overdose deaths appear to have dipped below 70,000 in 2018: CDC

NEW YORK (AP) — U.S. overdose deaths last year likely fell for the first time in nearly three decades, preliminary numbers suggest. The Centers for Disease Control and Prevention on Wednesday posted data showing nearly 68,000 drug overdose deaths were reported last year. The number may go up as more investigations are completed, but the agency expects the tally will […]

Read more

Stocks slightly higher as investors weigh contrary China trade reports; Boeing weigh on Dow

U.S. stocks edged mostly higher Thursday morning, as investors parsed conflicting reports on U.S. China trade relations, while the Dow fell amid reports of a new flaw with Boeing Co.’s troubled 737 MAX jet fleet. The Dow Jones Industrial Average DJIA, -0.07% lost 18 points, or 0.1%, to 26,521, dragged lower by Boeing Co.’s BA, -2.40% shares, which fell 2.8% early […]

Read more

Weekend roundup: The Uber IPO | China trade fight heats up | 16 ways Americans waste money

MarketWatch rounds up 10 of its most interesting topics over the past week. Uber Technologies UBER, -1.09% fell below its offering price in the initial minutes of its hyped stock-market debut. The car-share company priced its shares at $45 a share and expects to raise at least $8.1 billon. At that price, the entire company would be worth more than $75 […]

Read more

Gilead shares slip 0.2% after second NASH trial fails

Shares of Gilead Sciences Inc. GILD, -0.38% slipped 0.2% in premarket trade Thursday after the company said a late-stage study looking at selonsertib as a treatment for patients with liver scarring due to nonalcoholic steatohepatitis (NASH) did not meet its primary endpoint. A Phase 3 study of 802 subjects found that the drug failed to improve liver scarring, or fibrosis, […]

Read more

Centene’s stock shoots up after profit and revenue beat, raised outlook

Shares of Centene Corp. CNC, -0.25% shot up 6.1% in premarket trade Tuesday after the health-care services company reported first-quarter profit and revenue that beat expectations and raised its full-year outlook. Net income rose to $522 million, or $1.24 a share, from $340 million, or 96 cents a share, in the year-ago period. Excluding non-recurring items, adjusted EPS was $1.39, […]

Read more

Health-care stocks could rebound after their worst week of the year

The S&P 500 health-care sector falls 4.4%, its worst weekly decline since late December. Health care’s sharp drop comes as investors worry that left-leaning policy ideas such as universal health coverage are gaining support, which could hinder corporate profits for companies in the space. “Because this latest move was largely caused by political hot air (so to speak) and not […]

Read more

You can capture a dividend above 5% and still enjoy stock-market growth

A 5% yield is difficult to come by these days, even if income is your only objective. But the Gabelli Healthcare and Wellness Trust has a distribution yield above 5% and also pursues long-term growth. Jeff Jonas, who co-manages the fund, described his investment strategy and spoke about several representative stocks in an interview. The fund seeks long-term growth while […]

Read more
1 2 3 8